The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors

NCT02050243 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Central Nervous System Tumor, Pediatric

Interventions

DRUG: 5ALA

Sponsor

Tel-Aviv Sourasky Medical Center